A Cortical Pathogenic Theory of Parkinson's Disease
- PMID: 30236282
- DOI: 10.1016/j.neuron.2018.07.028
A Cortical Pathogenic Theory of Parkinson's Disease
Abstract
In Parkinson's disease, the progressive neurodegeneration of nigrostriatal dopaminergic neurons in the substantia nigra pars compacta (SNc) is associated with classic motor features, which typically have a focal onset. Since a defined somatotopic arrangement in the SNc has not been recognized, this focal motor onset is unexplained and hardly justified by current pathogenic theories of bottom-up disease progression (Braak's hypothesis, prionopathy). Here we propose that corticostriatal activity may represent a critical somatotopic "stressor" for nigrostriatal terminals, ultimately driving retrograde nigrostriatal degeneration and leading to focal motor onset and progression of Parkinson's disease. As a pathogenic mechanism, corticostriatal activity may promote secretion of striatal extracellular alpha-synuclein, favoring its pathological aggregation at vulnerable dopaminergic synapses. A similar pathogenic process may occur at corticofugal projections to the medulla oblongata and other vulnerable structures, thereby contributing to the bottom-up progression of Lewy pathology. This cortical pathogenesis may co-exist with bottom-up mechanisms, adding an integrative top-down perspective to the quest for the factors that impinge upon the vulnerability of dopaminergic cells in the onset and progression of Parkinson's disease.
Keywords: Parkinson’s disease; alpha-synuclein; basal ganglia; cortex; corticostriatal; dopamine; nigrostriatal; somatotopy.
Copyright © 2018 Elsevier Inc. All rights reserved.
Similar articles
-
Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit.Brain. 2021 Dec 16;144(11):3477-3491. doi: 10.1093/brain/awab242. Brain. 2021. PMID: 34297092 Free PMC article.
-
Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction.Brain. 2020 Mar 1;143(3):944-959. doi: 10.1093/brain/awaa019. Brain. 2020. PMID: 32057084
-
Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.Brain. 2013 Aug;136(Pt 8):2369-78. doi: 10.1093/brain/awt196. Brain. 2013. PMID: 23884809
-
RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.Mol Pharmacol. 2020 Dec;98(6):730-738. doi: 10.1124/mol.119.118836. Epub 2020 Feb 3. Mol Pharmacol. 2020. PMID: 32015009 Free PMC article. Review.
-
Determinants of dopaminergic neuron loss in Parkinson's disease.FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14. FEBS J. 2018. PMID: 30028088 Free PMC article. Review.
Cited by
-
A Critical LRRK at the Synapse? The Neurobiological Function and Pathophysiological Dysfunction of LRRK2.Front Mol Neurosci. 2020 Aug 27;13:153. doi: 10.3389/fnmol.2020.00153. eCollection 2020. Front Mol Neurosci. 2020. PMID: 32973447 Free PMC article. Review.
-
Revealing the Roles of MOAP1 in Diseases: A Review.Cells. 2022 Mar 4;11(5):889. doi: 10.3390/cells11050889. Cells. 2022. PMID: 35269511 Free PMC article. Review.
-
The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.Cell. 2022 Jun 9;185(12):2035-2056.e33. doi: 10.1016/j.cell.2022.05.008. Cell. 2022. PMID: 35688132 Free PMC article.
-
Parkinson's disease: Is it a consequence of human brain evolution?Mov Disord. 2019 Apr;34(4):453-459. doi: 10.1002/mds.27628. Epub 2019 Feb 13. Mov Disord. 2019. PMID: 30759321 Free PMC article. No abstract available.
-
Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.Mol Brain. 2021 Sep 16;14(1):143. doi: 10.1186/s13041-021-00848-w. Mol Brain. 2021. PMID: 34530877 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous